Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2988-2999
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2988
Table 1 Summary of patient characteristics in the older and younger groups
ParameterOverall (n = 614)Age ≥ 80 (n = 146)Age < 80 (n = 468)P value
Age [median (IQR)] (yr)68 (54-79)83 (81-86)62 (50-71)
Charlson score [median (IQR)]0 (0-1)1 (0-2)0 (0-1)0.001a
Charlson score ≥ 221% (129)29.5% (43)18.4% (86)0.005b
ERCP procedure time [median (IQR)] (min)30 (23-45)30 (23-45)30 (24-45)0.711a
Cannulation time [median (IQR)] (min)3.6 (0.8-11.8)3.4 (0.8-11.2)3.7 (0.8-12)0.292a
Male53.2% (327)51.4% (75)53.8% (252)0.636b
Cannulation success rate96.7% (595)96.6% (141)96.8% (454)0.547b
Indications
Biliary stones82.4% (506)82.9% (121)82.3% (385)0.468b
Benign strictures12.7% (78)11% (16)13.2% (62)0.287b
Cholangiocarcinoma4.2% (26)4.8% (7)4.1% (19)0.424b
Cholangitis9.1% (56)6.8% (10)9.8% (46)0.180b
Biliary pancreatitis5.9% (36)4.8% (7)6.2% (29)0.346b
Chronic pancreatitis1.3% (8)0% (0)1.7% (8)0.113b
Ampullary carcinoma3.3% (20)5.5% (8)2.6% (12)0.076b
Pancreatic cancer3.6% (22)2.7% (4)3.8% (18)0.371b
Comorbidities
Hypertension29.5% (181)38.4% (56)26.7% (125)0.009b
Cardiac diseases7.5% (46)15.1% (22)5.1% (24)< 0.001b
Diabetes mellitus11.7% (72)13% (19)11.3% (53)0.558b
Neurological diseases12.5% (77)21.9% (32)9.6% (45)< 0.001b
Hepatic diseases7.8% (48)5.5% (8)8.5% (40)0.290b
Malignancy9.3% (57)11% (16)8.8% (41)0.256b
Others9.9% (61)14.4% (21)8.5% (40)0.031b
Periampullary diverticulum19.7% (121)29.5% (43)16.7% (78)0.001b
Cannulation grade of difficulty
Easy cannulation66% (405)67.1% (98)65.6% (307)0.621b
Moderate cannulation11.7% (72)10.3% (15)12.2% (57)0.658b
Difficult cannulation22.3% (137)22.6% (33)22.2% (104)0.910b
Second ERCP20.4% (125)20.5% (30)20.3% (95)0.512b
Adverse events9.8% (60)13% (19)8.8% (41)0.089b
PEP5.2% (32)2.7% (4)6% (28)0.088b
Perforation0.5% (3)0.7% (1)0.4% (2)0.557b
Bleeding1.9% (12)4.1% (6)1.3% (6)0.111b
Cholangitis0.6% (4)0.7% (1)0.6% (3)0.663b
Cardiopulmonary0.6% (4)0.7% (1)0.6% (3)0.443b
Duration of hospitalization [median (IQR)] (d)9 (6-13)9 (7-13)9 (6-13)0.208a
Pancreatic stent10.4% (64)7.5% (11)11.3% (53)0.124b
Anti-thrombotic drug5.5% (34)7.5% (11)4.9% (23)< 0.001b